CalseƱa, Glaiza .
HRN: 27-04-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2025
CEFUROXIME 500MG (TAB)
05/13/2025
05/20/2025
PO
500mg
BID
S/p CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes